Condom use and the risk of genital human papillomavirus infection in young women.

PubWeight™: 5.69‹?› | Rank: Top 1%

🔗 View Article (PMID 16790697)

Published in N Engl J Med on June 22, 2006

Authors

Rachel L Winer1, James P Hughes, Qinghua Feng, Sandra O'Reilly, Nancy B Kiviat, King K Holmes, Laura A Koutsky

Author Affiliations

1: Department of Epidemiology, University of Washington, Seattle, USA. rlw@u.washington.edu

Associated clinical trials:

Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers (Girasol) | NCT00925288

Articles citing this

(truncated to the top 100)

Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis (2008) 3.19

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep (2009) 2.31

How will HPV vaccines affect cervical cancer? Nat Rev Cancer (2006) 2.23

Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14

Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res (2008) 1.73

The Strong Protective Effect of Circumcision against Cancer of the Penis. Adv Urol (2011) 1.63

Human papillomavirus and HPV vaccines: a review. Bull World Health Organ (2007) 1.55

Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health (2010) 1.53

Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control (2009) 1.52

Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol (2009) 1.45

Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. J Infect Dis (2013) 1.43

Sexually transmitted infection incidence among adolescents in Ireland. J Fam Plann Reprod Health Care (2014) 1.39

Sexual orientation disparities in cancer-related risk behaviors of tobacco, alcohol, sexual behaviors, and diet and physical activity: pooled Youth Risk Behavior Surveys. Am J Public Health (2013) 1.26

Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev (2010) 1.21

Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study. BMJ (2012) 1.19

Detection of genital HPV types in fingertip samples from newly sexually active female university students. Cancer Epidemiol Biomarkers Prev (2010) 1.18

Are condoms the answer to rising rates of non-HIV sexually transmitted infections? Yes. BMJ (2008) 1.17

Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol (2013) 1.11

Condoms and sexually-transmitted infections. N Engl J Med (2006) 1.09

Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral Oncol (2013) 1.09

The quality of life of patients with genital warts: a qualitative study. BMC Public Health (2010) 1.09

Predictors of using a microbicide-like product among adolescent girls. J Adolesc Health (2007) 1.08

Update on prevention and screening of cervical cancer. World J Clin Oncol (2014) 1.07

Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development. J Med Virol (2009) 1.06

Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries. Sex Transm Infect (2012) 1.06

Human Papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis (2009) 1.06

Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. J Infect Dis (2011) 1.05

Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands. PLoS One (2008) 1.04

Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health (2013) 1.01

Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies. BMC Public Health (2012) 1.01

Anal cancer - a review. Int J Health Sci (Qassim) (2012) 1.01

Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol (2009) 1.00

Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol (2011) 0.98

Assessing perceived risk and STI prevention behavior: a national population-based study with special reference to HPV. PLoS One (2011) 0.96

Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women. Sex Transm Dis (2012) 0.96

Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis (2009) 0.96

Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection. Am J Obstet Gynecol (2009) 0.94

Interventions for encouraging sexual behaviours intended to prevent cervical cancer. Cochrane Database Syst Rev (2011) 0.94

Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United States. J Infect Dis (2012) 0.94

Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa. BMC Med (2010) 0.93

Attitudes of men in an Australian male tolerance study towards microbicide use. Sex Health (2008) 0.91

Mediation by peer violence victimization of sexual orientation disparities in cancer-related tobacco, alcohol, and sexual risk behaviors: pooled youth risk behavior surveys. Am J Public Health (2014) 0.91

Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol (2012) 0.89

The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types. Cancer Epidemiol Biomarkers Prev (2010) 0.89

Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women. J Infect Dis (2012) 0.89

New approach to managing genital warts. Can Fam Physician (2013) 0.89

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J (2013) 0.88

Long-term cumulative detection of human papillomavirus among HIV seropositive women. AIDS (2014) 0.88

Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment. BMC Infect Dis (2010) 0.87

Relationships, love and sexuality: what the Filipino teens think and feel. BMC Public Health (2009) 0.86

Interventions to prevent sexually transmitted infections, including HIV infection. Clin Infect Dis (2011) 0.86

Unethical approach. Dtsch Arztebl Int (2015) 0.86

Cervical human papillomavirus infection among female sex workers in southern Vietnam. Infect Agent Cancer (2008) 0.85

Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents. J Adolesc Health (2008) 0.85

The use of web-based diaries in sexual risk behaviour research: a systematic review. Sex Transm Infect (2014) 0.85

Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly. Int J Cancer (2015) 0.83

Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study. BMC Infect Dis (2012) 0.83

Women at risk for sexually transmitted diseases: correlates of intercourse without barrier contraception. Am J Obstet Gynecol (2007) 0.83

Management of adolescents who have abnormal cytology and histology. Obstet Gynecol Clin North Am (2008) 0.83

Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis. J Infect Dis (2014) 0.82

Patterns of adolescent sexual behavior predicting young adult sexually transmitted infections: a latent class analysis approach. Arch Sex Behav (2014) 0.82

Adherence to dual-method contraceptive use. Contraception (2011) 0.82

Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus. PLoS One (2014) 0.81

Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries. Infect Dis Obstet Gynecol (2011) 0.81

Effect of sexual debut on vaginal microbiota in a cohort of young women. Obstet Gynecol (2012) 0.81

School-based intervention for the prevention of HPV among adolescents: a cluster randomised controlled study. BMJ Open (2016) 0.80

Would you say you had unprotected sex if ...? Sexual health language in emails to a reproductive health website. Cult Health Sex (2010) 0.80

Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination? BMC Public Health (2008) 0.79

Oncogenic Human Papillomavirus Infections in 18- to 24-Year-Old Female Online Daters. Sex Transm Dis (2015) 0.78

Human papillomavirus: what every provider should know. Am J Obstet Gynecol (2012) 0.78

Safe-sex belief and sexual risk behaviours among adolescents from three developing countries: a cross-sectional study. BMJ Open (2015) 0.78

Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women. Int J Cancer (2016) 0.78

Perspective for prophylaxis and treatment of cervical cancer: an immunological approach. Int Rev Immunol (2012) 0.77

A case-control study of sporadic retinoblastoma in relation to maternal health conditions and reproductive factors: a report from the Children's Oncology group. BMC Cancer (2015) 0.77

HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study. BMC Infect Dis (2013) 0.77

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for the introduction of HPV vaccines. Eur J Pediatr (2009) 0.77

Gardasil® - The New HPV Vaccine: The Right Product, the Right Time? A Commentary. Healthc Policy (2010) 0.76

Disparities by Sexual Orientation in Frequent Engagement in Cancer-Related Risk Behaviors: A 12-Year Follow-Up. Am J Public Health (2016) 0.76

Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya. Infect Agent Cancer (2016) 0.76

High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa. PLoS One (2016) 0.76

Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection. Sex Transm Dis (2009) 0.76

In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel. Gynecol Oncol (2016) 0.75

Human papillomavirus vaccine: a boon or curse. Hum Vaccin Immunother (2014) 0.75

HBV infection in relation to consistent condom use: a population-based study in Peru. PLoS One (2011) 0.75

Nigerian secondary school adolescents' perspective on abstinence-only sexual education as an effective tool for promotion of sexual health. F1000Res (2013) 0.75

Prevalence, Potential Predictors, and Genotype-Specific Prevalence of Human Papillomavirus Infection among Sexually Active Students in Japan. PLoS One (2015) 0.75

Oral and genital HPV genotypic concordance between sexual partners. Clin Oral Investig (2013) 0.75

Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches. Dermatol Ther (Heidelb) (2017) 0.75

Knowledge, awareness, and perception of contraception among senior pharmacy students in Malaysia: A pilot study. J Res Pharm Pract (2015) 0.75

Rapid acquisition of HPV around the time of sexual debut in adolescent girls in Tanzania. Int J Epidemiol (2016) 0.75

Condom use and the risk of HPV infection. N Engl J Med (2006) 0.75

Breast cancer policy in Latin America: account of achievements and challenges in five countries. Global Health (2016) 0.75

Attitudes and perceptions towards HPV vaccination among young women in Saudi Arabia. J Family Community Med (2016) 0.75

Cross-cultural differences and sexual risk behavior of emerging adults. J Transcult Nurs (2014) 0.75

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. BMC Infect Dis (2013) 0.75

Condom use and the risk of HPV infection. N Engl J Med (2006) 0.75

Loop Electrosurgical Excisional Procedure (LEEP) Done for Discrepancy: Does the Time from HGSIL Affect Pathologic Grade of CIN in LEEP Specimen? Obstet Gynecol Int (2010) 0.75

Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens. Infect Agent Cancer (2008) 0.75

Oral sex and oropharyngeal cancer: The role of the primary care physicians. Medicine (Baltimore) (2016) 0.75

Self-reported sex partner dates for use in measuring concurrent sexual partnerships: correspondence between two assessment methods. Arch Sex Behav (2014) 0.75

Articles by these authors

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med (2007) 12.17

Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep (2009) 11.30

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol (2005) 9.67

Global health in medical education: a call for more training and opportunities. Acad Med (2007) 8.85

Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials (2006) 7.50

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol (2003) 7.35

Global health training and international clinical rotations during residency: current status, needs, and opportunities. Acad Med (2009) 6.31

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis (2009) 5.09

Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol (2006) 4.33

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst (2010) 4.20

Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med (2005) 3.96

Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis (2011) 3.78

The epidemiology of human papillomavirus infections. J Clin Virol (2005) 3.63

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J Infect Dis (2009) 3.55

Human L1 element target-primed reverse transcription in vitro. EMBO J (2002) 3.54

Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis (2007) 3.48

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ (2010) 3.41

Update on syphilis: resurgence of an old problem. JAMA (2003) 3.31

Association between Mycoplasma genitalium and acute endometritis. Lancet (2002) 3.27

Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis (2008) 3.19

Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis (2004) 3.18

Partner reduction is crucial for balanced "ABC" approach to HIV prevention. BMJ (2004) 3.12

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet (2007) 3.10

HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS (2002) 3.03

Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med (2008) 2.98

HIV serosorting in men who have sex with men: is it safe? J Acquir Immune Defic Syndr (2008) 2.91

Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis (2003) 2.88

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep (2002) 2.86

Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol (2008) 2.80

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine (2006) 2.78

HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru. J Acquir Immune Defic Syndr (2007) 2.71

Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst (2006) 2.67

A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62

Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck (2009) 2.59

"It takes a village": understanding concurrent sexual partnerships in Seattle, Washington. Sex Transm Dis (2002) 2.56

Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51

Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One (2010) 2.48

Sex partner concurrency: measurement, prevalence, and correlates among urban 18-39-year-olds. Sex Transm Dis (2002) 2.46

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) (2009) 2.42

Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci U S A (2004) 2.39

Genital human papillomavirus infection in men. Lancet Infect Dis (2006) 2.39

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA (2002) 2.37

Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One (2011) 2.36

Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis (2009) 2.26

Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sex Transm Dis (2006) 2.21

Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis (2008) 2.21

Do people really know their sex partners? Concurrency, knowledge of partner behavior, and sexually transmitted infections within partnerships. Sex Transm Dis (2004) 2.19

Sexual identity and risk of HIV/STI among men who have sex with men in Nairobi. Sex Transm Dis (2008) 2.11

Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis (2006) 2.10

Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis (2002) 2.09

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine (2008) 2.09

Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst (2005) 2.08

Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep (2004) 2.05

Discord, discordance, and concurrency: comparing individual and partnership-level analyses of new partnerships of young adults at risk of sexually transmitted infections. Sex Transm Dis (2005) 2.05

Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey. Lancet Infect Dis (2012) 2.03

Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr (2010) 2.01

Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis (2002) 1.99

Development and performance of a microwell-plate-based polymerase chain reaction assay for Mycoplasma genitalium. Sex Transm Dis (2003) 1.99

Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol (2008) 1.96

Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol (2003) 1.91

Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis (2003) 1.91

Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis (2002) 1.87

Text messaging to improve attendance at post-operative clinic visits after adult male circumcision for HIV prevention: a randomized controlled trial. PLoS One (2012) 1.85

Handheld computers for self-administered sensitive data collection: a comparative study in Peru. BMC Med Inform Decis Mak (2008) 1.82

Comprehensive health care for people infected with HIV in developing countries. BMJ (2002) 1.81

Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet (2012) 1.80

Epidemic Lymphogranuloma venereum during epidemics of crack cocaine use and HIV infection in the Bahamas. Sex Transm Dis (2002) 1.79

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect (2011) 1.78

Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis (2012) 1.78

Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health (2007) 1.78

Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev (2011) 1.74

Measuring sex partner concurrency: it's what's missing that counts. Sex Transm Dis (2007) 1.73

Determinants and prevalence of HIV infection in pregnant Peruvian women. AIDS (2003) 1.72